Spinal Cord Trauma Treatment Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030
CHAPTER 1. Industry Overview of Spinal Cord Trauma Treatment Market
1.1. Definition and Scope
1.1.1. Definition of Spinal Cord Trauma Treatment
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Spinal Cord Trauma Treatment Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Spinal Cord Trauma Treatment Market By Treatment Type
1.2.3. Spinal Cord Trauma Treatment Market By Injury
1.2.4. Spinal Cord Trauma Treatment Market By End-User
1.2.5. Spinal Cord Trauma Treatment Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Spinal Cord Trauma Treatment Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Spinal Cord Trauma Treatment Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Spinal Cord Trauma Treatment Market By Treatment Type
4.1. Introduction
4.2. Spinal Cord Trauma Treatment Revenue By Treatment Type
4.2.1. Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast, By Treatment Type, 2018-2030
4.2.2. Spinal Traction
4.2.2.1. Spinal Traction Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Corticosteroid
4.2.3.1. Corticosteroid Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.4. Surgery
4.2.4.1. Surgery Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Spinal Cord Trauma Treatment Market By Injury
5.1. Introduction
5.2. Spinal Cord Trauma Treatment Revenue By Injury
5.2.1. Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast, By Injury, 2018-2030
5.2.2. Partial Spinal Cord Injury
5.2.2.1. Partial Spinal Cord Injury Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Complete Spinal Cord Injury
5.2.3.1. Complete Spinal Cord Injury Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Spinal Cord Trauma Treatment Market By End-User
6.1. Introduction
6.2. Spinal Cord Trauma Treatment Revenue By End-User
6.2.1. Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast, By End-User, 2018-2030
6.2.2. Trauma Centers
6.2.2.1. Trauma Centers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Hospitals
6.2.3.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Others
6.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Spinal Cord Trauma Treatment Market By Country
7.1. North America Spinal Cord Trauma Treatment Market Overview
7.2. U.S.
7.2.1. U.S. Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
7.2.2. U.S. Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
7.2.3. U.S. Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.3. Canada
7.3.1. Canada Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
7.3.2. Canada Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
7.3.3. Canada Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Spinal Cord Trauma Treatment Market By Country
8.1. Europe Spinal Cord Trauma Treatment Market Overview
8.2. U.K.
8.2.1. U.K. Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
8.2.2. U.K. Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
8.2.3. U.K. Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.3. Germany
8.3.1. Germany Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
8.3.2. Germany Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
8.3.3. Germany Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.4. France
8.4.1. France Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
8.4.2. France Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
8.4.3. France Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.5. Spain
8.5.1. Spain Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
8.5.2. Spain Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
8.5.3. Spain Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
8.6.2. Rest of Europe Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
8.6.3. Rest of Europe Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Spinal Cord Trauma Treatment Market By Country
9.1. Asia Pacific Spinal Cord Trauma Treatment Market Overview
9.2. China
9.2.1. China Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
9.2.2. China Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
9.2.3. China Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.3. Japan
9.3.1. Japan Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
9.3.2. Japan Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
9.3.3. Japan Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.4. India
9.4.1. India Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
9.4.2. India Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
9.4.3. India Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.5. Australia
9.5.1. Australia Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
9.5.2. Australia Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
9.5.3. Australia Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.6. South Korea
9.6.1. South Korea Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
9.6.2. South Korea Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
9.6.3. South Korea Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
9.7.2. Rest of Asia-Pacific Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
9.7.3. Rest of Asia-Pacific Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Spinal Cord Trauma Treatment Market By Country
10.1. Latin America Spinal Cord Trauma Treatment Market Overview
10.2. Brazil
10.2.1. Brazil Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
10.2.2. Brazil Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
10.2.3. Brazil Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.3. Mexico
10.3.1. Mexico Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
10.3.2. Mexico Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
10.3.3. Mexico Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
10.4.2. Rest of Latin America Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
10.4.3. Rest of Latin America Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Spinal Cord Trauma Treatment Market By Country
11.1. Middle East & Africa Spinal Cord Trauma Treatment Market Overview
11.2. GCC
11.2.1. GCC Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
11.2.2. GCC Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
11.2.3. GCC Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.3. South Africa
11.3.1. South Africa Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
11.3.2. South Africa Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
11.3.3. South Africa Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Treatment Type, 2018-2030
11.4.2. Rest of Middle East & Africa Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By Injury, 2018-2030
11.4.3. Rest of Middle East & Africa Spinal Cord Trauma Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Spinal Cord Trauma Treatment Market
12.1. Spinal Cord Trauma Treatment Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Spinal Cord Trauma Treatment Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Acorda Therapeutics, Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2021
13.1.3.2. Acorda Therapeutics, Inc. 2021 Spinal Cord Trauma Treatment Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Asterias Biotherapeutics
13.3. BioArctic AB
13.4. BioTime, Inc.
13.5. InVivo Therapeutic
13.6. Kringle Pharma, Inc.
13.7. Medtronic Plc
13.8. Novartis AG
13.9. Pfizer Inc.
13.10. Pharmicell Co. Ltd.
13.11. ReNetX Bio
Frequently Asked Questions
What is the size of global spinal cord trauma treatment market in 2021?
The market size of spinal cord trauma treatment market in 2021 was accounted to be USD 3.8 Billion.
What is the CAGR of global spinal cord trauma treatment market during forecast period of 2022 to 2030?
The projected CAGR of spinal cord trauma treatment market during the analysis period of 2022 to 2030 is 3.6%.
Which are the key players operating in the market?
The prominent players of the global spinal cord trauma treatment market are Acorda Therapeutics, Inc., Asterias Biotherapeutics, BioArctic AB, BioTime, Inc., InVivo Therapeutic, Kringle Pharma, Inc., Medtronic, Novartis AG, Pfizer Inc., Pharmicell Co. Ltd., and ReNetX Bio.
Which region held the dominating position in the global spinal cord trauma treatment market?
North America held the dominating spinal cord trauma treatment during the analysis period of 2022 to 2030.
Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for spinal cord trauma treatment during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global spinal cord trauma treatment market?
Rising prevalence of traumatic spinal cord injuries, growing cases of chronic disorders, and surging incidences of sport injuries drives the growth of global spinal cord trauma treatment market.
Which treatment type held the maximum share in 2021?
Based on treatment type, surgery segment is expected to hold the maximum share spinal cord trauma treatment market.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
